Advanced Instruments launches Advanced Automated Osmometer Advanced Instruments.

The announcement was produced at the American Association for Clinical Chemistry’s 2011 Clinical Lab Expo. ‘It combines a highly functional design, exceptional functionality, and an intuitive software program control package that’s both effective and elegantly simple to operate. The instrument fully automates sample processing to accomplish dramatic benefits in laboratory efficiency and efficiency. The instrument’s flexible software program brings exciting new features and benefits to medical laboratories: Intuitive touchscreen user interface provides easy-to-use efficiency and procedure Integrated quality control features include automated system calibration, statistical reporting and monitoring, method control limits for patient and controls samples, and built-in program linearity checks Selectable system operation and access levels provides operator login and password security Positive sample identification eliminates transcription errors Sample testing protocols could be customized specifically for each laboratory’s unique test requirements ‘Advanced Instruments offers leveraged its 50 years of freezing-point technology knowledge to revolutionize osmolality examining,’ stated Peterson.’..Combining Evalve’s 1st in class mitral valve repair technology with Abbott’s global presence, infrastructure and manufacturing experience will help advance minimally invasive treatment plans for the an incredible number of individuals with mitral regurgitation, stated Robert Hance, senior vice president, vascular, Abbott. We anticipate welcoming Evalve as a key part of Abbott’s vascular business. Patients in European countries have benefited from access the MitraClip technology since it received CE Mark last year, stated Ferolyn Powell, president and chief executive officer of Evalve, who will continue to lead the Evalve group and will report to Hance after the acquisition closes. We look forward to becoming a part of Abbott and operating collectively to accelerate our business and broaden our global reach to sufferers around the world with our minimally invasive technologies.